Indefinite Delivery Contract SPE2DB24D9230

This indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide.

Through this vehicle, DMS Pharmaceutical Group provides both routine and specialized medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables. Specific items supplied under task orders include Botox, Xtandi capsules, Mirena contraceptive systems, and Surgilube lubricant. These pharmaceutical and medical supply deliveries support the diverse medical requirements of military personnel and their dependents across various DoD health facilities. The contract does not have any set-aside designations, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for this pharmaceutical Prime Vendor program.